Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

Keyphrases

• Hematopoietic Stem Cell Transplantation 100%
• Inborn Errors of Immunity 100%
• Event-free Survival 55%
• Overall Survival 44%
• Transplant Outcomes 22%
• Splenectomy 22%
• Bronchiectasis 22%
• Malignancy 11%
• Risk Factors 11%
• Comorbidity 11%
• High Risk 11%
• Adverse Outcomes 11%
• Graft-versus-host Disease (GvHD) 11%
• Associated Complications 11%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 11%
• Curative Treatment 11%
• Age-independent 11%
• Univariate Analysis 11%
• Multivariable 11%
• Low Dose Rate 11%
• Severe Acute 11%
• Independent Risk Factors 11%
• Single-center Study 11%
• Specific Risk 11%
• Systemic Immunosuppression 11%
• Hematopoietic Cell Transplant 11%
• Transplant-related Mortality 11%
• Colitis 11%
• Hepatic Dysfunction 11%
• Organ Damage 11%
• Index Score 11%
• Comorbidity Index 11%
• Inflammatory Lung Disease 11%
• Primary Antibody Deficiency 11%

Immunology and Microbiology

• Hematopoietic Stem Cell Transplantation 100%
• Primary Immunodeficiency 100%
• Adolescence 100%
• Event Free Survival 55%
• Overall Survival 44%
• Comorbidity 22%
• Allogeneic Hematopoietic Stem Cell Transplantation 11%
• Graft-Versus-Host Disease 11%
• Hematopoietic Cell 11%
• Immunosuppression 11%
• Humoral Immune Deficiency 11%
• Colitis 11%